Young Investigator Awards
MRA Young Investigator Awards aim to attract early career scientists with novel ideas into melanoma research, thereby recruiting and supporting the next generation of melanoma researchers. Young Investigators are scientists within four years of their first academic faculty appointment. A mentorship commitment from a senior investigator is required.
To learn more about MRA funded research awards, please visit CureMelanoma.org/Grants
Enhancing an Abscopal Response by Elucidating the Role of Stem-Like T-Cells
ASTRO-MRA Young Investigator Award in Radiation Oncology
Zachary Buchwald MD, PhD, Emory University
Targeting Liver Metastases to Enhance Immunotherapy Efficacy in Melanoma
MRA Young Investigator Award, collaboratively funded by The University of Michigan
Michael Green MD, The University of Michigan
Dissecting the role of CD58 in Cancer Immune Evasion and T Cell Exclusion
Tara Miller Melanoma Foundation — MRA Young Investigator Award
Benjamin Izar MD, PhD, Columbia University Medical Center
Dissecting Tumor and Immune Evolution in Unresectable In-Transit Melanoma
Amanda and Jonathan Eilian — MRA Young Investigator Award
David Liu MD, Dana-Farber Cancer Institute
Targeting SPP to Activate Antigen Presentation in Melanoma via HLA-E
MRA Young Investigator Award, collaboratively funded by the Broad Institute
Robert Manguso PhD, The Broad Institute
Tumor Microbiome Potentiates Cancer Immunotherapy in Melanoma
Bristol Myers Squibb — MRA Young Investigator Award
Marlies Meisel PhD, University of Pittsburgh
Uncoupling MEK and ERK To Treat Melanoma
MRA Young Investigator Award
Gatien Moriceau PhD, The University of California, Los Angeles
Delineating Novel Mechanism of Immune Evasion in Melanoma Brain Metastases
MRA Young Investigator Award
Inan Olmez MD, Pennsylvania State University
Mitochondrial Uncoupling: A New Therapeutic Approach for Melanoma
Merck — MRA Young Investigator Award
Rachel Perry PhD, Yale University School of Medicine
Understanding and Improving Neoepitope-Specific T Cell Response to Melanoma
Leveraged Finance Fights Melanoma-MRA Young Investigator Award
Cristina Puig Saus PhD, The University of California, Los Angeles
Immunotherapeutic Cytokine/Antibody Fusion Proteins to Treat Melanoma
MRA Young Investigator Award
Jamie Spangler PhD, Johns Hopkins University-School of Medicine
Improving Immunotherapy Outcomes Through Solving irAEs
Bristol Myers Squibb — MRA Young Investigator Award
Alexandra-Chloe Villani PhD, Massachusetts General Hospital
Adipocyte Remodelling in Melanoma Progression and Immunotherapy Response
MRA Young Investigator Award
Amaya Viros MD, PhD, The University of Manchester
Targeting CDK6 in T Cells for Melanoma Therapy
Bristol Myers Squibb — MRA Young Investigator Award
Haizhen Wang PhD, Medical University of South Carolina
Since its founding in 2007, the Melanoma Research Alliance has become the largest non-profit funder of melanoma research worldwide. Through 380 awards, MRA has directly invested more than $131 million, and leveraged an additional $415 million in collaborative and follow-on funding towards its mission. MRA is catalyzing strategic, collaborative, and accountable research efforts that have moved the field forward and given patients and their loved ones better treatment options and renewed hope.
To learn more about MRA funded research awards, please visit CureMelanoma.org/Grants
